GlassScriptPhysician profile
Kevin C Brown
NPI 1528413325
$4,553.51
in general payments reported to CMS, 2019-2025
10 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.44 · 2021: $140 · 2022: $207 · 2023: $2,352 · 2024: $682 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275 · Travel and Lodging: $1,812 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.88 |
| Travel and Lodging | $1,812.29 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,790.07 | 2023 | |
| Intuitive Surgical, INC. | $600.65 | 2025 | |
| Davol INC. | $494.68 | 2020-2025 | Phasix Mesh |
| Medtronic, INC. | $464.96 | 2022-2023 | Signia, Dextile, Progrip |
| W. L. Gore & Associates, INC. | $444.17 | 2021-2023 | Seamguard, Gore Enform Preperitoneal Biomaterial |
| Baxter Healthcare | $383.41 | 2024 | Perclot, Tisseel |
| Tela Bio, INC. | $251.23 | 2024 | Ovitex 2s |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Conmed Corporation | $32.26 | 2024 | Airseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.59 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.